American Health Packaging Recalls Oxcarbazepine, Ibuprofren for Mislabeled Packages

Columbus, Ohio-based American Health Packaging has voluntarily recalled one lot of ibuprofen tablets and one lot of oxcarbazepine tablets due to mislabeled packaging.

The recalled ibuprofen tablets may contain individual blistered doses labeled as oxcarbazepine tablets. AHP also recalled the oxcarbazepine tablets due to a mislabeled blister packaging which could result in patients receiving ibuprofen instead.

If a patient misses a dose of oxcarbazepine, used to treat certain type of epileptic seizures, the risk for a seizure increases. Additionally, if a patient accidently consumes ibuprofen, it may cause adverse reactions, according to the U.S. Food and Drug Administration notification regarding the recall.

More Articles on Recalls:

Baxter Initiates Worldwide Saline Solution Recall
5 Health IT Safety Issues Hospital Executives Should Monitor
OR Implants and the Case for Supply Chain Automation

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars